|
|
| |
|
REGULATION OF INTRACELLULAR
IRON METABOLISM
|
| |
|
|
Tracey
Rouault, M.D., Principal Investigator
Emmanuel Bourdon, Visiting Fellow
Sharon Cooperman, M.D., Senior Fellow
Steven Drake, Ph.D., Postdoctoral
Fellow
Manik Ghosh, Senior Fellow
Colette Hess, Ph.D., Guest Researcher
Laura Jui-Chen, M.D., Postdoctoral Fellow
William Land, Predoctoral Fellow
Timothy Lavaute, Senior Research Assistant
Alan Martinez, Predoctoral Fellow
Esther Meyron-Holtz, Ph.D., Postdoctoral
Fellow
Sophia Smith, M.D., Senior Fellow
Wing Hang Tong, Ph.D., Senior
Fellow
Alan Koretsky, Ph.D., Collaborator,
LFMI, NINDS
Rodney Levine, M.D., Ph.D. Collaborator,
LB, NHLBI
Robert Nussbaum, M.D. Collaborator,
GDRB, NHGRI
Victor Gordeuk, M.D. Collaborator, Hematology, Howard Medical Center, Washington
DC, USA
Steven Holbrook, Ph.D. Collaborator, Berkeley, CA, USA
|
|
|
| |
|
In earlier years, the laboratory identified and characterized the cis
and trans elements mediating the iron-dependent alterations in the abundance
of ferritin and the transferrin receptor. Iron-responsive elements (IREs)
are RNA stem-loops found in the 5' end of ferritin mRNA and the 3' end
of transferrin receptor mRNA. We have cloned, expressed, and characterized
two essential iron-sensing proteins, Iron Regulatory Protein 1 (IRP1)
and Iron Regulatory Protein 2 (IRP2). IRPs bind to IREs when iron levels
are depleted, resulting in the inhibition of translation of ferritin mRNA
and other IRE-containing transcripts and prolongation of the half-life
of the transferrin receptor mRNA. IRP1 is an iron-sulfur protein related
to mitochondrial aconitase, a citric acid cycle enzyme. It functions as
a cytosolic aconitase in cells that are iron replete. Regulation of RNA-binding
activity of IRP1 involves a transition from a form of IRP1 in which a
[4Fe-4S] cluster is bound to a form that loses both iron and aconitase
activity. The [4Fe-4S]-containing protein does not bind to IREs. Controlled
degradation of the iron-sulfur cluster and mutagenesis reveals that the
physiologically relevant form of the RNA binding protein in iron-depleted
cells is apoprotein. The status of the cluster appears to determine whether
IRP1 will bind RNA.
The Molecular Basis of Intracellular Iron Metabolism
Recently, we have identified mammalian enzymes of iron-sulfur cluster
assembly that are homologous to the NifS and Nif U genes implicated in
bacterial iron-sulfur cluster assembly, and we have shown that these gene
products facilitate assembly of the iron- sulfur cluster of IRP1. IRP2
also binds to IREs in iron-depleted cells, but, unlike IRP1, IRP2 is degraded
in cells that are iron replete. Experimental evidence indicates that IRP2
binds to iron and undergoes iron-catalyzed oxidation. The oxidized protein
is then selectively ubiquitinated and degraded by the proteasome. Indirect
evidence suggests that numerous other proteins are degraded by a pathway
in which oxidative modification is followed by ubiquitination and proteasomal
degradation of the ubiquitinated substrate. To approach questions about
the physiology of iron metabolism, loss of function mutations of IRP1
and IRP2 have been generated in mice through homologous recombination
in embryonic cell lines. In the absence of provocative stimuli, there
are no abnormalities in iron metabolism associated with loss of IRP1 function.
IRP2-/-mice develop a progressive movement disorder characterized by gait
abnormalities and tremor. Animals develop axonal degeneration characterized
by iron accumulation in axons. Ferritin overexpression occurs in affected
neurons, and ferritin accumulation occurs in axons. Affected cells are
those that depend mainly on IRP2 for repression of ferritin translation.
Animals that lack both IRP1 and IRP2 are embryonic lethal. Blastocyst
harvest may yield cells that completely lack IRPs.
|
| |
|
PUBLICATIONS
- Bolan
CD, Conry-Cantilena C, Mason G, Rouault TA, Leitman SF. MCV as a
guide to phlebotomy therapy for hemochromatosis. Transfusion 2001;41:819-827.
- Gangaidzo
IT, Moyo VM, Mvundura E, Aggrey G, Murphree, NL, Khumalo H, Saungweme
T, Kasvosve I, Gomo ZA, Rouault T, Boelaert JR, Gordeuk VR. Association
of pulmonary tuberculosis with increased dietary iron. J Infect Dis
2001;184:936-939.
- LaVaute
T, Smith S, Cooperman S, Iwai K, Land W, Meyron-Holtz E, Drake SK, Miller
G, Abu-Asab M, Tsokos M, Switzer R, Grinberg A, Love P, Tresser N, Rouault
TA. Targeted deletion of the gene encoding iron regulatory protein-2
causes misregulation of iron metabolism and neurodegenerative disease
in mice. Nat Genet 2001;27:209-214.
- Loyevsky
M, LaVaute T, Allerson CR, Stearman R, Kassim OO, Cooperman S, Gordeuk
VR, Rouault TA. An IRP-like protein from Plasmodium falciparum binds
to a mammalian iron-responsive element. Blood 2001;98:2555-2562.
- Rouault TA. Connective tissue disease. In: Medicine 2000; in press.
- Rouault
TA. Iron on the brain. Nat Genet 2001;28:299-300.
- Rouault TA. Iron-responsive elements in humans. In: Encyclopedia of
molecular medicine, in press.
- Rouault TA. Monoarticular arthritis. In: Medicine 2001; in press.
- Rouault TA. Polyarthritis. In: Medicine 2001; in press.
- Rouault
TA. Systemic iron metabolism: a review and implications for brain
iron metabolism. Pediatr Neurol 2001;25:130-137.
- Rouault TA. Vasculitis. In: Medicine 2000; in press.
|
| |
|
|